Zhang Kaina, Zheng Yeqing, Bao Gaowa, Ma Wenzhuo, Han Bing, Shi Hongwen, Zhao Zhenghang
Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Institute of Cardiovascular Sciences, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Antioxidants (Basel). 2023 Aug 22;12(9):1657. doi: 10.3390/antiox12091657.
Recent studies have shown that FMS-like receptor tyrosine kinase 3 (Flt3) has a beneficial effect on cardiac maladaptive remodeling. However, the role and mechanism of Flt3 in mitochondrial dynamic imbalance under cardiac stress remains poorly understood. This study aims to investigate how Flt3 regulates p53-mediated optic atrophy 1 (OPA1) processing and mitochondrial fragmentation to improve cardiac remodeling. Mitochondrial fragmentation in cardiomyocytes was induced by isoprenaline (ISO) and HO challenge, respectively, in vitro. Cardiac remodeling in mice was established by ligating the left anterior descending coronary artery or by chronic ISO challenge, respectively, in vivo. Our results demonstrated that the protein expression of acetylated-p53 (ac-p53) in mitochondria was significantly increased under cell stress conditions, facilitating the dissociation of PHB2-OPA1 complex by binding to prohibitin 2 (PHB2), a molecular chaperone that stabilizes OPA1 in mitochondria. This led to the degradation of the long isoform of OPA1 (L-OPA1) that facilitates mitochondrial fusion and resultant mitochondrial network fragmentation. This effect was abolished by a p53 K371R mutant that failed to bind to PHB2 and impeded the formation of the ac-p53-PHB2 complex. The activation of Flt3 significantly reduced ac-p53 expression in mitochondria via SIRT1, thereby hindering the formation of the ac-p53-PHB2 complex and potentiating the stability of the PHB2-OPA1 complex. This ultimately inhibits L-OPA1 processing and leads to the balancing of mitochondrial dynamics. These findings highlight a novel mechanism by which Flt3 activation mitigates mitochondrial fragmentation and dysfunction through the reduction of L-OPA1 processing by dampening the interaction between ac-p53 and PHB2 in cardiac maladaptive remodeling.
最近的研究表明,FMS样受体酪氨酸激酶3(Flt3)对心脏适应性不良重塑具有有益作用。然而,Flt3在心脏应激下线粒体动态失衡中的作用和机制仍知之甚少。本研究旨在探讨Flt3如何调节p53介导的视神经萎缩蛋白1(OPA1)加工和线粒体分裂以改善心脏重塑。在体外,分别用异丙肾上腺素(ISO)和HO刺激诱导心肌细胞中的线粒体分裂。在体内,分别通过结扎左冠状动脉前降支或慢性ISO刺激建立小鼠心脏重塑模型。我们的结果表明,在细胞应激条件下,线粒体中乙酰化p53(ac-p53)的蛋白表达显著增加,通过与禁止素2(PHB2)结合促进PHB2-OPA1复合物的解离,PHB2是一种在线粒体中稳定OPA1的分子伴侣。这导致促进线粒体融合的OPA1长异构体(L-OPA1)降解,从而导致线粒体网络碎片化。这种作用被未能与PHB2结合并阻碍ac-p53-PHB2复合物形成的p53 K371R突变体所消除。Flt3的激活通过SIRT1显著降低线粒体中ac-p53的表达,从而阻碍ac-p53-PHB2复合物的形成并增强PHB2-OPA1复合物的稳定性。这最终抑制L-OPA1加工并导致线粒体动力学平衡。这些发现突出了一种新机制,即Flt3激活通过减少心脏适应性不良重塑中ac-p53与PHB2之间的相互作用来减轻线粒体碎片化和功能障碍,从而减少L-OPA1加工。